Potentiator that Enhances Mucociliary Transport to Treat Cystic Fibrosis and other Mucus Obstructive Diseases

by | Jun 2, 2026 | Alexander-Brett, Jennifer, Berry, Kayla, Brett, Thomas, Miller, Mark, Nichols, Colin, Sala-Rabanal, Monica, Yurtsever, Zeynep

— Published date: 6/3/2026

Value Proposition: Using CLCA1 VWA to specifically potentiate TMEM16A to enhance mucociliary transport in cystic fibrosis and other mucus obstructive diseases.

Technology Description

Researchers at Washington University in St. Louis have developed a potentiator, CLCA1 …